BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 27426018)

  • 1. Prostate specific antigen (PSA) in diagnosis of polycystic ovarian syndrome - a new insight.
    Rudnicka E; Radowicki S; Suchta K
    Gynecol Endocrinol; 2016 Nov; 32(11):931-935. PubMed ID: 27426018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combination of ovarian volume and outline has better diagnostic accuracy than prostate-specific antigen (PSA) concentrations in women with polycystic ovarian syndrome (PCOs).
    Bili E; Dampala K; Iakovou I; Tsolakidis D; Giannakou A; Tarlatzis BC
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():32-5. PubMed ID: 24965976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
    Vural B; Ozkan S; Bodur H
    J Obstet Gynaecol Res; 2007 Apr; 33(2):166-73. PubMed ID: 17441890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum prostate specific antigen levels in women with polycystic ovary syndrome and the effect of flutamide+desogestrel/ethinyl estradiol combination.
    Bahceci M; Bilge M; Tuzcu A; Tuzcu S; Bahceci S
    J Endocrinol Invest; 2004 Apr; 27(4):353-6. PubMed ID: 15233555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of prostatic specific antigen in hirsute women.
    Güllü S; Emral R; Asik M; Cesur M; Tonyukuk V
    J Endocrinol Invest; 2003 Dec; 26(12):1198-202. PubMed ID: 15055472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum complexed and free prostate-specific antigen (PSA) for the diagnosis of the polycystic ovarian syndrome (PCOS).
    Diamandis EP; Stanczyk FZ; Wheeler S; Mathew A; Stengelin M; Nikolenko G; Glezer EN; Brown MD; Zheng Y; Chen YH; Wu HL; Azziz R
    Clin Chem Lab Med; 2017 Oct; 55(11):1789-1797. PubMed ID: 28361781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing the cut off values of androgen markers in the assessment of polycystic ovarian syndrome.
    Nadaraja RND; Sthaneshwar P; Razali N
    Malays J Pathol; 2018 Apr; 40(1):33-39. PubMed ID: 29704382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome.
    Hahn S; Kuehnel W; Tan S; Kramer K; Schmidt M; Roesler S; Kimmig R; Mann K; Janssen OE
    Clin Chem Lab Med; 2007; 45(2):202-7. PubMed ID: 17311509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Value of Prostate-Specific Antigen in Diagnosis of Polycystic Ovarian Syndrome in Adolescent Girls.
    Tokmak A; Bodur S; Erkilinc S; Ozel S; Engin-Ustun Y
    J Pediatr Adolesc Gynecol; 2018 Jun; 31(3):263-269. PubMed ID: 29162532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostatic-specific antigen (PSA) levels in patients with polycystic ovary syndrome (PCOS): a meta-analysis.
    Wu ZH; Tang Y; Niu X; Pu FF; Xiao XY; Kong W
    J Ovarian Res; 2019 Oct; 12(1):94. PubMed ID: 31615559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of prostate-specific antigen (PSA) and free prostate specific antigen (fPSA) in women with ovulatory and anovulatory polycystic ovary syndrome.
    UKINC K; Ersoz HO; Erem C; Hacihasanoglu AB
    Endocrine; 2009 Feb; 35(1):123-9. PubMed ID: 19009369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ratio of prostate-specific antigen (PSA) to prostate volume (PSA density) as a parameter to improve the detection of prostate carcinoma in PSA values in the range of < 4 ng/mL.
    Stephan C; Stroebel G; Heinau M; Lenz A; Roemer A; Lein M; Schnorr D; Loening SA; Jung K
    Cancer; 2005 Sep; 104(5):993-1003. PubMed ID: 16007682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome?
    Catteau-Jonard S; Bancquart J; Poncelet E; Lefebvre-Maunoury C; Robin G; Dewailly D
    Ultrasound Obstet Gynecol; 2012 Aug; 40(2):223-9. PubMed ID: 22648908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between hyperandrogenism, obesity, inflammation and polycystic ovary syndrome.
    Nehir Aytan A; Bastu E; Demiral I; Bulut H; Dogan M; Buyru F
    Gynecol Endocrinol; 2016 Sep; 32(9):709-713. PubMed ID: 26951881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy.
    Auprich M; Augustin H; Budäus L; Kluth L; Mannweiler S; Shariat SF; Fisch M; Graefen M; Pummer K; Chun FK
    BJU Int; 2012 Jun; 109(11):1627-35. PubMed ID: 21939492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen Profile Through Life in Women With Polycystic Ovary Syndrome: A Nordic Multicenter Collaboration Study.
    Pinola P; Piltonen TT; Puurunen J; Vanky E; Sundström-Poromaa I; Stener-Victorin E; Ruokonen A; Puukka K; Tapanainen JS; Morin-Papunen LC
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3400-7. PubMed ID: 26192874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining hyperandrogenism in polycystic ovary syndrome: measurement of testosterone and androstenedione by liquid chromatography-tandem mass spectrometry and analysis by receiver operator characteristic plots.
    Barth JH; Field HP; Yasmin E; Balen AH
    Eur J Endocrinol; 2010 Mar; 162(3):611-5. PubMed ID: 20008514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological variation of total testosterone, free androgen index and bioavailable testosterone in polycystic ovarian syndrome: implications for identifying hyperandrogenaemia.
    Cho LW; Kilpatrick ES; Jayagopal V; Diver MJ; Atkin SL
    Clin Endocrinol (Oxf); 2008 Mar; 68(3):390-4. PubMed ID: 17888022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of various prostate specific antigen ratios for the early detection of prostate cancer.
    Ozdal OL; Aprikian AG; Bégin LR; Behlouli H; Tanguay S
    BJU Int; 2004 May; 93(7):970-4; discussion 974. PubMed ID: 15142145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate-specific antigen and human glandular kallikrein 2 are markedly elevated in urine of patients with polycystic ovary syndrome.
    Obiezu CV; Scorilas A; Magklara A; Thornton MH; Wang CY; Stanczyk FZ; Diamandis EP
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1558-61. PubMed ID: 11297583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.